Catalog |
name |
Description |
price |
R-M-2083 |
Alkyne-Val-Cit-PAB-FAM |
Alkyne-Val-Cit-PAB-FAM,Alkyne-Val-Cit-PAB-fluorescein from ruixi.Alkyne-Val-Cit-PAB-FAM is a cleavable peptide linker. The Val-Cit linker can bespecifically cleaved by Cathepsin B. |
price> |
R-M-2085 |
Mal-amido-PEG8-Val-Gly,Cas:2353409-54-6 |
Mal-amido-PEG8-Val-Gly,Cas:2353409-54-6 from ruixi.Mal-amido-PEG8-Val-Gly is a peptide linker. |
price> |
R-M-2087 |
Azido-PEG4-Ala-Ala-Asn(Trt)-PAB,Cas:2055042-67-4 |
Azido-PEG4-Ala-Ala-Asn(Trt)-PAB is a unique peptide cleavable ADC linker for antibody-drug-conjugation, Azido group is very reactive toward DBCO, BCN or other Alkyne groups, called click chemistry. The trt protecting group can be removed under acidic conditions. The hydrophilic PEG linker increases the water solubility of the compound. |
price> |
R-M-2088 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP,Cas:2055042-82-3 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP is a peptide reagent for ADC conjugation, it possesses a cleavable peptide sequence. PEG spacer increases the aqueous solubility. |
price> |
R-M-2090 |
Fmoc-PEG4-Ala-Ala-Asn-PAB,Cas:2055048-57-0 |
Fmoc-PEG4-Ala-Ala-Asn-PAB is a unique peptide cleavable peptide linker, PEG spacer increases the aqueous solubility. |
price> |
R-M-2092 |
Azido-PEG5-Ala-Ala-Asn-PAB,Cas:2055048-54-7 |
Azido-PEG5-Ala-Ala-Asn-PAB PAB is a unique peptide cleavable ADC linker for antibody-drug-conjugation, Azido group is very reactive toward DBCO, BCN or other Alkyne groups, called click chemistry. PEG spacer increases the aqueous solubility. |
price> |
R-M-2093 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB,Cas:2055042-69-6 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB PAB is a unique peptide cleavable ADC linker for antibody-drug-conjugation, PEG spacer increases the aqueous solubility. |
price> |
R-M-2094 |
Val-Cit-PAB-MMAE,Cas:644981-35-1 |
Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains a a protease-sensitive Val-Cit dipeptide, and a MMAE payload. The MMAE is a synthetic antineoplastic agent. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells. |
price> |
R-M-2095 |
MC-Val-Cit-PAB-MMAE,Cas:646502-53-6 |
MC-Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate. It contains a thio reactive maleimidocaproyl (MC) group, a protease-sensitive Val-Cit dipeptide, a PABC linker and a MMAE payload. The MMAE is a synthetic antineoplastic agent. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells. |
price> |
R-M-2096 |
Fmoc-Val-Cit-PAB-MMAE,Cas:1350456-56-2 |
Fmoc-Val-Cit-PAB-MMAE is a precursor of antibody drug conjugate containing a cleavable Val-Cit peptide, a PABC linker and a MMAE payload. It can be attached to a monoclonal antibody (MAB) which directs it toward cancer cells. |
price> |